PDB Short entry for 5MRA HEADER METAL BINDING PROTEIN 22-DEC-16 5MRA TITLE HUMAN SCBD (SORCIN CALCIUM BINDING DOMAIN) IN COMPLEX WITH DOXORUBICIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SORCIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: 22 KDA PROTEIN,CP-22,CP22,V19; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SRI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SORCIN (SOLUBLE RESISTANCE-RELATED CALCIUM BINDING PROTEIN), METAL KEYWDS 2 BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.ILARI,A.FIORILLO,G.COLOTTI,I.GENOVESE REVDAT 2 17-JAN-24 5MRA 1 LINK REVDAT 1 29-NOV-17 5MRA 0 JRNL AUTH I.GENOVESE,A.FIORILLO,A.ILARI,S.MASCIARELLI,F.FAZI,G.COLOTTI JRNL TITL BINDING OF DOXORUBICIN TO SORCIN IMPAIRS CELL DEATH AND JRNL TITL 2 INCREASES DRUG RESISTANCE IN CANCER CELLS. JRNL REF CELL DEATH DIS V. 8 E2950 2017 JRNL REFN ISSN 2041-4889 JRNL PMID 28726784 JRNL DOI 10.1038/CDDIS.2017.342 REMARK 2 REMARK 2 RESOLUTION. 3.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0155 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 76.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 11193 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 569 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.74 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.83 REMARK 3 REFLECTION IN BIN (WORKING SET) : 765 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.52 REMARK 3 BIN R VALUE (WORKING SET) : 0.3500 REMARK 3 BIN FREE R VALUE SET COUNT : 46 REMARK 3 BIN FREE R VALUE : 0.3700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5226 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 1 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 177.2 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.39000 REMARK 3 B22 (A**2) : -1.22000 REMARK 3 B33 (A**2) : 8.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.700 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.600 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5376 ; 0.010 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 4910 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7277 ; 1.324 ; 1.954 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11241 ; 1.001 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 664 ;10.988 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 268 ;41.362 ;23.955 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 872 ;20.699 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 41 ;17.064 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 784 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6242 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1327 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2668 ; 9.837 ;17.775 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2667 ; 9.834 ;17.774 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3328 ;15.746 ;26.628 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3329 ;15.743 ;26.629 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2708 ; 8.501 ;18.249 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2709 ; 8.500 ;18.252 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3950 ;14.184 ;27.207 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6492 ;21.040 ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6493 ;21.038 ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5MRA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1200002883. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9677 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER R 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11800 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.740 REMARK 200 RESOLUTION RANGE LOW (A) : 76.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.530 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.8100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.47 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4UPG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MGCL2, 0.1 M TRIS PH=7, NACL 2.5 REMARK 280 M, PH 7, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 46.11450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.63650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.41550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.63650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 46.11450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.41550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -61.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 175 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 135 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 136 CG CD1 CD2 REMARK 470 ILE B 144 CG1 CG2 CD1 REMARK 470 LYS B 146 CG CD CE NZ REMARK 470 LYS B 153 CG CD CE NZ REMARK 470 LYS C 68 CG CD CE NZ REMARK 470 LYS C 96 CG CD CE NZ REMARK 470 THR C 178 OG1 CG2 REMARK 470 ARG D 84 CG CD NE CZ NH1 NH2 REMARK 470 GLN D 139 CG CD OE1 NE2 REMARK 470 LYS D 146 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 48 136.60 -174.07 REMARK 500 ALA B 43 81.03 51.70 REMARK 500 PHE B 134 35.61 71.68 REMARK 500 PRO B 187 174.56 -57.73 REMARK 500 PRO C 69 179.01 -50.47 REMARK 500 LEU C 72 -50.46 -26.55 REMARK 500 THR C 74 -60.85 -27.18 REMARK 500 ASP C 83 91.38 -59.71 REMARK 500 MET C 90 116.60 -164.45 REMARK 500 PHE C 112 -54.03 -133.04 REMARK 500 PRO C 138 -9.21 -55.99 REMARK 500 SER C 149 -39.33 -32.02 REMARK 500 THR C 150 8.30 58.12 REMARK 500 TYR C 159 -71.12 -46.02 REMARK 500 ARG C 176 -75.80 -63.86 REMARK 500 ALA D 43 48.26 33.54 REMARK 500 LEU D 82 61.27 -114.11 REMARK 500 PHE D 134 -166.85 -103.82 REMARK 500 SER D 137 59.80 -156.77 REMARK 500 ASN D 151 -0.02 69.67 REMARK 500 GLN D 180 74.73 66.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 46 GLY A 47 -129.85 REMARK 500 THR A 178 ALA A 179 147.58 REMARK 500 MET B 132 GLY B 133 146.43 REMARK 500 GLY C 133 PHE C 134 -146.83 REMARK 500 PHE C 134 ARG C 135 -139.42 REMARK 500 GLY D 65 GLY D 66 -148.46 REMARK 500 SER D 117 GLY D 118 -149.35 REMARK 500 THR D 119 VAL D 120 144.50 REMARK 500 TYR D 148 SER D 149 -143.23 REMARK 500 THR D 170 ASP D 171 149.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 83 OD1 REMARK 620 2 ASP A 85 OD2 90.3 REMARK 620 3 THR A 89 O 63.5 149.1 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 87 OG REMARK 620 2 THR B 89 O 57.8 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG C 201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ALA C 43 O REMARK 620 2 ASP C 46 OD1 71.4 REMARK 620 3 GLN C 48 O 69.8 80.7 REMARK 620 4 HOH C 301 O 159.0 93.9 123.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG C 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C 83 OD1 REMARK 620 2 ARG C 84 O 99.8 REMARK 620 3 THR C 89 OG1 92.1 166.6 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG D 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP D 85 OD1 REMARK 620 2 THR D 89 O 109.2 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG D 201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP D 115 OD1 REMARK 620 2 GLU D 124 OE1 151.2 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS B 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DM2 B 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG C 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG C 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG D 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG D 202 DBREF 5MRA A 33 198 UNP P30626 SORCN_HUMAN 33 198 DBREF 5MRA B 33 198 UNP P30626 SORCN_HUMAN 33 198 DBREF 5MRA C 33 198 UNP P30626 SORCN_HUMAN 33 198 DBREF 5MRA D 33 198 UNP P30626 SORCN_HUMAN 33 198 SEQADV 5MRA MET A 32 UNP P30626 INITIATING METHIONINE SEQADV 5MRA MET B 32 UNP P30626 INITIATING METHIONINE SEQADV 5MRA MET C 32 UNP P30626 INITIATING METHIONINE SEQADV 5MRA MET D 32 UNP P30626 INITIATING METHIONINE SEQRES 1 A 167 MET ASP PRO LEU TYR GLY TYR PHE ALA ALA VAL ALA GLY SEQRES 2 A 167 GLN ASP GLY GLN ILE ASP ALA ASP GLU LEU GLN ARG CYS SEQRES 3 A 167 LEU THR GLN SER GLY ILE ALA GLY GLY TYR LYS PRO PHE SEQRES 4 A 167 ASN LEU GLU THR CYS ARG LEU MET VAL SER MET LEU ASP SEQRES 5 A 167 ARG ASP MET SER GLY THR MET GLY PHE ASN GLU PHE LYS SEQRES 6 A 167 GLU LEU TRP ALA VAL LEU ASN GLY TRP ARG GLN HIS PHE SEQRES 7 A 167 ILE SER PHE ASP THR ASP ARG SER GLY THR VAL ASP PRO SEQRES 8 A 167 GLN GLU LEU GLN LYS ALA LEU THR THR MET GLY PHE ARG SEQRES 9 A 167 LEU SER PRO GLN ALA VAL ASN SER ILE ALA LYS ARG TYR SEQRES 10 A 167 SER THR ASN GLY LYS ILE THR PHE ASP ASP TYR ILE ALA SEQRES 11 A 167 CYS CYS VAL LYS LEU ARG ALA LEU THR ASP SER PHE ARG SEQRES 12 A 167 ARG ARG ASP THR ALA GLN GLN GLY VAL VAL ASN PHE PRO SEQRES 13 A 167 TYR ASP ASP PHE ILE GLN CYS VAL MET SER VAL SEQRES 1 B 167 MET ASP PRO LEU TYR GLY TYR PHE ALA ALA VAL ALA GLY SEQRES 2 B 167 GLN ASP GLY GLN ILE ASP ALA ASP GLU LEU GLN ARG CYS SEQRES 3 B 167 LEU THR GLN SER GLY ILE ALA GLY GLY TYR LYS PRO PHE SEQRES 4 B 167 ASN LEU GLU THR CYS ARG LEU MET VAL SER MET LEU ASP SEQRES 5 B 167 ARG ASP MET SER GLY THR MET GLY PHE ASN GLU PHE LYS SEQRES 6 B 167 GLU LEU TRP ALA VAL LEU ASN GLY TRP ARG GLN HIS PHE SEQRES 7 B 167 ILE SER PHE ASP THR ASP ARG SER GLY THR VAL ASP PRO SEQRES 8 B 167 GLN GLU LEU GLN LYS ALA LEU THR THR MET GLY PHE ARG SEQRES 9 B 167 LEU SER PRO GLN ALA VAL ASN SER ILE ALA LYS ARG TYR SEQRES 10 B 167 SER THR ASN GLY LYS ILE THR PHE ASP ASP TYR ILE ALA SEQRES 11 B 167 CYS CYS VAL LYS LEU ARG ALA LEU THR ASP SER PHE ARG SEQRES 12 B 167 ARG ARG ASP THR ALA GLN GLN GLY VAL VAL ASN PHE PRO SEQRES 13 B 167 TYR ASP ASP PHE ILE GLN CYS VAL MET SER VAL SEQRES 1 C 167 MET ASP PRO LEU TYR GLY TYR PHE ALA ALA VAL ALA GLY SEQRES 2 C 167 GLN ASP GLY GLN ILE ASP ALA ASP GLU LEU GLN ARG CYS SEQRES 3 C 167 LEU THR GLN SER GLY ILE ALA GLY GLY TYR LYS PRO PHE SEQRES 4 C 167 ASN LEU GLU THR CYS ARG LEU MET VAL SER MET LEU ASP SEQRES 5 C 167 ARG ASP MET SER GLY THR MET GLY PHE ASN GLU PHE LYS SEQRES 6 C 167 GLU LEU TRP ALA VAL LEU ASN GLY TRP ARG GLN HIS PHE SEQRES 7 C 167 ILE SER PHE ASP THR ASP ARG SER GLY THR VAL ASP PRO SEQRES 8 C 167 GLN GLU LEU GLN LYS ALA LEU THR THR MET GLY PHE ARG SEQRES 9 C 167 LEU SER PRO GLN ALA VAL ASN SER ILE ALA LYS ARG TYR SEQRES 10 C 167 SER THR ASN GLY LYS ILE THR PHE ASP ASP TYR ILE ALA SEQRES 11 C 167 CYS CYS VAL LYS LEU ARG ALA LEU THR ASP SER PHE ARG SEQRES 12 C 167 ARG ARG ASP THR ALA GLN GLN GLY VAL VAL ASN PHE PRO SEQRES 13 C 167 TYR ASP ASP PHE ILE GLN CYS VAL MET SER VAL SEQRES 1 D 167 MET ASP PRO LEU TYR GLY TYR PHE ALA ALA VAL ALA GLY SEQRES 2 D 167 GLN ASP GLY GLN ILE ASP ALA ASP GLU LEU GLN ARG CYS SEQRES 3 D 167 LEU THR GLN SER GLY ILE ALA GLY GLY TYR LYS PRO PHE SEQRES 4 D 167 ASN LEU GLU THR CYS ARG LEU MET VAL SER MET LEU ASP SEQRES 5 D 167 ARG ASP MET SER GLY THR MET GLY PHE ASN GLU PHE LYS SEQRES 6 D 167 GLU LEU TRP ALA VAL LEU ASN GLY TRP ARG GLN HIS PHE SEQRES 7 D 167 ILE SER PHE ASP THR ASP ARG SER GLY THR VAL ASP PRO SEQRES 8 D 167 GLN GLU LEU GLN LYS ALA LEU THR THR MET GLY PHE ARG SEQRES 9 D 167 LEU SER PRO GLN ALA VAL ASN SER ILE ALA LYS ARG TYR SEQRES 10 D 167 SER THR ASN GLY LYS ILE THR PHE ASP ASP TYR ILE ALA SEQRES 11 D 167 CYS CYS VAL LYS LEU ARG ALA LEU THR ASP SER PHE ARG SEQRES 12 D 167 ARG ARG ASP THR ALA GLN GLN GLY VAL VAL ASN PHE PRO SEQRES 13 D 167 TYR ASP ASP PHE ILE GLN CYS VAL MET SER VAL HET MG A 201 1 HET MG A 202 1 HET MG A 203 1 HET MG B 201 1 HET MG B 202 1 HET DMS B 203 4 HET DM2 B 204 39 HET MG C 201 1 HET MG C 202 1 HET MG C 203 1 HET MG D 201 1 HET MG D 202 1 HETNAM MG MAGNESIUM ION HETNAM DMS DIMETHYL SULFOXIDE HETNAM DM2 DOXORUBICIN HETSYN DM2 ADRIAMYCIN FORMUL 5 MG 10(MG 2+) FORMUL 10 DMS C2 H6 O S FORMUL 11 DM2 C27 H29 N O11 FORMUL 17 HOH *(H2 O) HELIX 1 AA1 LEU A 35 ALA A 43 1 9 HELIX 2 AA2 ASP A 50 GLY A 62 1 13 HELIX 3 AA3 ASN A 71 LEU A 82 1 12 HELIX 4 AA4 GLY A 91 ASP A 113 1 23 HELIX 5 AA5 ASP A 121 MET A 132 1 12 HELIX 6 AA6 SER A 137 SER A 149 1 13 HELIX 7 AA7 PHE A 156 ASP A 177 1 22 HELIX 8 AA8 TYR A 188 MET A 196 1 9 HELIX 9 AA9 LEU B 35 VAL B 42 1 8 HELIX 10 AB1 ASP B 50 SER B 61 1 12 HELIX 11 AB2 ASN B 71 ARG B 84 1 14 HELIX 12 AB3 GLY B 91 ASP B 113 1 23 HELIX 13 AB4 ASP B 121 MET B 132 1 12 HELIX 14 AB5 SER B 137 TYR B 148 1 12 HELIX 15 AB6 PHE B 156 ASP B 177 1 22 HELIX 16 AB7 TYR B 188 VAL B 198 1 11 HELIX 17 AB8 LEU C 35 GLY C 44 1 10 HELIX 18 AB9 ASP C 50 GLY C 62 1 13 HELIX 19 AC1 ASN C 71 ASP C 83 1 13 HELIX 20 AC2 ARG C 84 SER C 87 5 4 HELIX 21 AC3 GLY C 91 SER C 111 1 21 HELIX 22 AC4 ASP C 121 MET C 132 1 12 HELIX 23 AC5 SER C 137 TYR C 148 1 12 HELIX 24 AC6 THR C 155 ARG C 175 1 21 HELIX 25 AC7 TYR C 188 VAL C 198 1 11 HELIX 26 AC8 LEU D 35 ALA D 41 1 7 HELIX 27 AC9 ASP D 50 GLY D 62 1 13 HELIX 28 AD1 ASN D 71 LEU D 82 1 12 HELIX 29 AD2 GLY D 91 ASP D 113 1 23 HELIX 30 AD3 ASP D 121 MET D 132 1 12 HELIX 31 AD4 SER D 137 SER D 149 1 13 HELIX 32 AD5 THR D 155 ASP D 177 1 23 HELIX 33 AD6 PRO D 187 MET D 196 1 10 SHEET 1 AA1 2 THR A 119 VAL A 120 0 SHEET 2 AA1 2 ILE A 154 THR A 155 -1 O ILE A 154 N VAL A 120 SHEET 1 AA2 2 VAL A 183 PRO A 187 0 SHEET 2 AA2 2 VAL B 183 PRO B 187 -1 O VAL B 184 N PHE A 186 SHEET 1 AA3 2 THR B 119 VAL B 120 0 SHEET 2 AA3 2 ILE B 154 THR B 155 -1 O ILE B 154 N VAL B 120 SHEET 1 AA4 2 VAL C 184 PRO C 187 0 SHEET 2 AA4 2 VAL D 183 PHE D 186 -1 O VAL D 184 N PHE C 186 LINK OD1 ASP A 83 MG MG A 202 1555 1555 2.75 LINK OD2 ASP A 85 MG MG A 202 1555 1555 2.93 LINK O THR A 89 MG MG A 202 1555 1555 2.86 LINK OD2 ASP A 115 MG MG A 201 1555 1555 2.74 LINK OG SER B 87 MG MG B 201 1555 1555 2.88 LINK O THR B 89 MG MG B 201 1555 1555 2.78 LINK OD1 ASP B 113 MG MG B 202 1555 1555 2.73 LINK O ALA C 43 MG MG C 201 1555 1555 2.75 LINK OD1 ASP C 46 MG MG C 201 1555 1555 2.61 LINK O GLN C 48 MG MG C 201 1555 1555 2.80 LINK OD1 ASP C 83 MG MG C 202 1555 1555 2.41 LINK O ARG C 84 MG MG C 202 1555 1555 2.55 LINK OG1 THR C 89 MG MG C 202 1555 1555 2.73 LINK OE2 GLU C 124 MG MG C 203 1555 1555 2.95 LINK MG MG C 201 O HOH C 301 1555 1555 2.99 LINK OD1 ASP D 85 MG MG D 202 1555 1555 2.47 LINK O THR D 89 MG MG D 202 1555 1555 2.21 LINK OD1 ASP D 115 MG MG D 201 1555 1555 2.77 LINK OE1 GLU D 124 MG MG D 201 1555 1555 2.94 SITE 1 AC1 3 PHE A 112 ASP A 115 GLU A 124 SITE 1 AC2 6 GLN A 48 ASP A 83 ASP A 85 SER A 87 SITE 2 AC2 6 THR A 89 GLU A 94 SITE 1 AC3 3 ASP A 50 ASP A 52 GLU A 53 SITE 1 AC4 5 ASP B 83 ASP B 85 SER B 87 THR B 89 SITE 2 AC4 5 GLU B 94 SITE 1 AC5 2 ASP B 113 GLU B 124 SITE 1 AC6 1 MET B 32 SITE 1 AC7 6 TYR A 188 PHE B 134 ARG B 174 ASP B 177 SITE 2 AC7 6 GLN B 181 GLY B 182 SITE 1 AC8 5 ALA C 43 ASP C 46 GLN C 48 GLU C 53 SITE 2 AC8 5 HOH C 301 SITE 1 AC9 5 ASP C 83 ARG C 84 ASP C 85 SER C 87 SITE 2 AC9 5 THR C 89 SITE 1 AD1 3 ASP C 113 THR C 114 GLU C 124 SITE 1 AD2 4 THR D 114 ASP D 115 THR D 119 GLU D 124 SITE 1 AD3 7 LEU D 82 ASP D 83 ARG D 84 ASP D 85 SITE 2 AD3 7 SER D 87 THR D 89 GLU D 94 CRYST1 92.229 104.831 113.273 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010843 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009539 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008828 0.00000